EXPLORING THE POTENTIAL OF TRIM PROTEINS AS THERAPEUTIC TARGETS IN OVARIAN CANCER: IMPLICATIONS FOR ATHLETE HEALTH AND PERFORMANCE

Authors

  • Yansong Hu The QUEEN MARY school, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang, Jiangxi 330031, China.
  • Tong Feng Department of Otolaryngology, Funing District Hospital of Traditional Chinese Medicine, Funing, Qinhuangdao, Hebei 066300, China.
  • Xiaochen Li Department of Small and medium-sized commercial bank supervision, Fushun Supervision Branch of the State Administration of Financial Supervision and Administration, 13 Xinhua Road, Fushun, Liaoning 113006, China.
  • Yunhui Pen The QUEEN MARY school, Jiangxi Medical College, Nanchang University, 999 Xuefu Road, Nanchang, Jiangxi 330031, China.
  • Ruyu Wen Department of Obstetrics and gynecology, The Second Affiliated Hospital, Jiangxi Medical College, Nanchang University, Nanchang, Jiangxi,330006, China.

Keywords:

Ovarian Cancer, TRIM Family, Carcinogenesis, Signaling Pathway, Target Therapy.

Abstract

Ovarian cancer remains a significant health concern among female athletes, impacting their well-being and athletic performance. The Tripartite Motif (TRIM) family of proteins, known for their versatile roles in cellular processes such as proliferation, invasion, and metastasis, are pivotal in the progression of ovarian cancer. These proteins function as both oncogenes and tumor suppressors, influencing the pathogenesis of this malignancy. This review delves into the signaling pathways that TRIM proteins modulate, contributing to the onset and advancement of ovarian cancer, with a focus on implications for female athletes. Understanding the complex relationship between TRIM proteins and ovarian cancer not only aids in identifying potential therapeutic targets but also enhances the management strategies tailored specifically for athlete health, ensuring their return to peak performance post-treatment and maintaining their long-term health.

Published

2024-02-01